DermBiont

About DermBiont

DermBiont is a company focused on advancing dermatology solutions, particularly in the treatment of skin disorders such as Melasma and hyperpigmentation, with an emphasis on leading a revolution in dermatology.

Products & Services

SM-030:A treatment being developed for Melasma and hyperpigmentation disorders of the skin.

Specialties

Treatment of Melasma Hyperpigmentation disorders Skin disorder treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 35200000 MR: - FA: 35.2 Million FAN: 35200000	D: 2023-10-24 FD: 2023-10-24	4 investors

Series B Latest

2023-10-24

$35.2M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Karl Beutner

Chief Executive Officer & Co-founder

N

Nichola Eliovits

Chief Financial Officer & Co-Founder

M

Max N. Dawson

Chief Operating Officer

E

Emma Taylor

Dermatology Advisor

D

Daniel Yadegar

Managing Partner

S

Steven Basta

Director

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

DermBiont Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised